← Back to Articles
GLP-1 AGONISTS
Retatrutide: Triple acting jab for type 2 diabetes lowers blood sugar and boosts weight loss, trial reports
Authors: Katharine Lang
Journal: BMJ (Clinical research ed.)
Authors: Katharine Lang
Journal: BMJ (Clinical research ed.)